Monoferric for Prenatal Iron Deficiency
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Early Phase 1
SUMMARY
A prospective observational study of pregnant women with iron deficiency anemia and oral iron intolerance or advanced gestational age.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: t
View:
• Participants 18 years of age or older between 14 to 42 weeks gestation who are deemed appropriate for IV iron by their treating provider as part of their standard of care treatment.
• Iron deficiency anemia, defined as second or third trimester (14 weeks or more) hemoglobin less than or equal to 10.5 g/dL or less than or equal to11 g/dL, respectively, and ferritin less than 50 μg/L
• Experience intolerance to oral iron or are greater than 28 weeks gestation
• Willing to participate in the study
Locations
United States
Oregon
Oregon Health & Science Univerity
RECRUITING
Portland
Contact Information
Primary
Women's Health Research Unit Research Unit Department of OB/Gyn
whru@ohsu.edu
503-494-3666
Time Frame
Start Date: 2024-01-18
Estimated Completion Date: 2028-10
Participants
Target number of participants: 80
Treatments
Experimental: Ferric derisomaltose
Related Therapeutic Areas
Sponsors
Leads: Oregon Health and Science University